Current Drug Targets - Cardiovascular & Hematological Disorders
Title: Editorial
Volume: 5 Issue: 1
Author(s): Alexandra Lucas
Affiliation:
Export Options
About this article
Cite this article as:
Lucas Alexandra, Editorial, Current Drug Targets - Cardiovascular & Hematological Disorders 2005; 5 (1) . https://dx.doi.org/10.2174/1568006053004976
DOI https://dx.doi.org/10.2174/1568006053004976 |
Print ISSN 1568-0061 |
Publisher Name Bentham Science Publisher |
Online ISSN 1568-0061 |
Related Journals
Related Books
12
Related Articles
-
Carotid Artery Atherosclerosis: What is the Evidence for Drug Action?
Current Pharmaceutical Design Controlling Apoptosis by Inhibition of Caspases
Current Medicinal Chemistry Nucleoside Transporter Proteins
Current Vascular Pharmacology Review Metabolomics: A New Approach to Drug Delivery in Perinatology
Current Medicinal Chemistry Hypertensive Pharmacogenomics in African Americans
Current Pharmacogenomics Editorial: Thematic Issue-Topic–Diabetic Cardiovascular Disease–An Unmet Medical Need: Emerging Targets and Therapies-Introduction to the Special Issue
Cardiovascular & Hematological Agents in Medicinal Chemistry Endothelins and the Role of Endothelin Antagonists in the Management of Posttraumatic Vasospasm
Current Pharmaceutical Design Future Therapeutic Directions: New Medications and Insulin Delivery in a Changing World for Effective Diabetes Management
Current Drug Discovery Technologies Vasculogenic and Angiogenic Pathways in Moyamoya Disease
Current Medicinal Chemistry Acute Decompensated Heart Failure Update
Current Cardiology Reviews Novel Therapies Targeting Cardioprotection and Regeneration
Current Pharmaceutical Design Receptor-Based 3D-QSAR Study for Recognizing True Binding Mode of Mercaptoacyldipeptides at the Active Site of Neutral Endopeptidase
Medicinal Chemistry Metabolic Effects of Resveratrol in Mammals - a Link Between Improved Insulin Action and Aging
Current Aging Science Repurposed Drugs in Metabolic Disorders
Current Topics in Medicinal Chemistry Dietary Antioxidants as Potential Pharmacological Agents for Ischemic Stroke
Current Medicinal Chemistry Molecular Effects of L-dopa Therapy in Parkinson’s Disease
Current Genomics Inflammatory Markers in Essential Hypertension: Potential Clinical Implications
Current Vascular Pharmacology Diagnostic and Therapeutic Potentials of microRNAs in Heart Failure
Current Topics in Medicinal Chemistry Protein kinases and the Hypoxia-Inducible Factor-1, two switches in angiogenesis
Current Pharmaceutical Design Do Advanced Glycation End Products (AGEs) Contribute to the Comorbidities of Polycystic Ovary Syndrome (PCOS)?
Current Pharmaceutical Design